CVE-2024-47530

Public Exploit

Scout contains an Open Redirect on Login via `next`

Description

Scout is a web-based visualizer for VCF-files. Open redirect vulnerability allows performing phishing attacks on users by redirecting them to malicious page. /login API endpoint is vulnerable to open redirect attack via next parameter due to absence of sanitization logic. Additionally, due to lack of scheme validation, HTTPS Downgrade Attack can be performed on the users. This vulnerability is fixed in 4.89.

References

Link	Tags
https://github.com/Clinical-Genomics/scout/security/advisories/GHSA-3x45-2m34-x95v	third party advisory exploit
https://github.com/Clinical-Genomics/scout/commit/50055edfca9a7183b248019af97e1fb0b0065a02	patch

Frequently Asked Questions

What is the severity of CVE-2024-47530?: CVE-2024-47530 has been scored as a medium severity vulnerability.
How to fix CVE-2024-47530?: To fix CVE-2024-47530, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-47530 being actively exploited in the wild?: It is possible that CVE-2024-47530 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-47530?: CVE-2024-47530 affects Clinical-Genomics scout.

This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.

Description

Category

CWE-601 – URL Redirection to Untrusted Site ('Open Redirect')

References

Frequently Asked Questions